Medtronic, Boston Scientific and other major device makers could be greatly affected by the health care reform effort under way in the capital. As Medtronic CEO William Hawkins puts it, the device industry stands to benefit from one group of proposals while losing ground in another. Reducing the number of uninsured Americans would help the industry, he said, but cost-containment efforts would put a lot of pressure on the industry to lower prices. Along with Medtronic and Boston Scientific, St. Jude Medical, Zimmer Holdings and Johnson & Johnson are some of the large device makers with a big stake in the reform outcome. (Click here for more – a subscription may be required)
“Medical-Device Stocks Rise As Pressure Ebbs, But Risks Remain” – Wall Street Journal (6/24/09)
Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com
